FIELD: medicine.
SUBSTANCE: in the tumor tissue taken during surgery, the level of the transcription factor kappa-B - NF-κB rb5 is determined and at its value of 16.0 CU/mg of protein per well and more, a high risk of relapse in a period of 6 to 24 months is predicted.
EFFECT: prediction of the risk of disease recurrence, objective control of the malignant process development, the assumption of relapses development before their clinical manifestation and inclusion of patients into risk groups for intensive surveillance, timely measures for adjuvant treatment appointment.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE TARGETED THERAPY WITH CETUXIMAB IN THE PATIENTS SUFFERING SQUAMOUS CELL CARCINOMA OF THE TONGUE AND ORAL MUCOSA | 2019 |
|
RU2713453C1 |
| METHOD FOR PREDICTION OF DEVELOPING LYMPHOGENIC METASTASES IN SQUAMOUS CELL CARCINOMA OF HEAD AND NECK FOLLOWING COMBINATION THERAPY | 2013 |
|
RU2527338C1 |
| METHOD FOR PREDICTING TUMOUR RESISTANCE TO TETHEGETH THERAPY OF CETUXIMAB IN PATIENTS WITH PLANE-CELLULAR LANGUAGE OF LANGUAGE AND MULTIDISAL BOTTOM OF THE PTA | 2016 |
|
RU2626682C1 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOME OF MUSCULO-INVASIVE BLADDER CANCER FOLLOWING COMBINATION THERAPY | 2012 |
|
RU2538632C2 |
| METHOD OF PREDICTION OF OUTCOMES IN PATIENTS WITH SQUAMOUS CELL CANCER OF THE ORAL MUCOSA | 2023 |
|
RU2802446C2 |
| METHOD OF INTRAOPERATIVE PHOTODYNAMIC THERAPY IN COMBINED TREATMENT OF PRIMARY LOCALLY ADVANCED TONGUE CANCER | 2022 |
|
RU2797433C1 |
| METHOD FOR PREDICTION OF DEVELOPING HAEMATOGENOUS METASTASES FOLLOWING COMBINED TREATMENT OF KIDNEY CANCER | 2013 |
|
RU2528100C1 |
| METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF TUMORS OF THE ORAL MUCOSA | 2017 |
|
RU2678041C1 |
| METHOD FOR SUTURING TONGUE STUMP | 1999 |
|
RU2152179C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF LEUKOPLAKIA AND SQUAMOUS CELL CARCINOMA OF THE ORAL MUCOSA AT THE PREOPERATIVE STAGE | 2021 |
|
RU2770354C1 |
